Genetic architecture for human aggression: A study of gene–phenotype relationship in OMIM

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 171, Issue 5, 2016, Pages 641-649

  Zhang James, Yanli ^a   Faraone, Stephen V ^a,b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

aggression; genetics; OMIM

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADRENALIN; DOPAMINE; NORADRENALIN; SEROTONIN;

AGGRESSION; AGGRESSIVENESS; ARTICLE; FUNCTIONAL ASSESSMENT; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCUS; GENETIC ALGORITHM; GENETIC ANALYSIS; GENETIC VARIATION; GENOTYPE PHENOTYPE CORRELATION; LONG TERM DEPRESSION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SYMPTOM; GENETIC ASSOCIATION STUDY; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RISK FACTOR;

AGGRESSION; DATABASES, GENETIC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RISK FACTORS;

EID: 84940184490     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32363     Document Type: Article

References (41)

1. Adamczyk A, Mejias R, Takamiya K, Yocum J, Krasnova IN, Calderon J, Cadet JL, Huganir RL, Pletnikov MV, Wang T. 2012. GluA3-deficiency in mice is associated with increased social and aggressive behavior and elevated dopamine in striatum. Behav Brain Res 229:265–272.
2. Alten R, Gomez-Reino J, Durez P, Beaulieu A, Sebba A, Krammer G, Preiss R, Arulmani U, Widmer A, Gitton X, Kellner H. 2011. Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, Phase II, dose-finding study. BMC musculoskeletal disorders 12:153.
3. An G, Nieman G, Vodovotz Y. 2012. Computational and systems biology in trauma and sepsis: Current state and future perspectives. Int J Burns Trauma 2:1–10.
4. Ballester J, Goldstein T, Goldstein B, Obreja M, Axelson D, Monk K, Hickey M, Iyengar S, Farchione T, Kupfer DJ, Brent D, Birmaher B. 2012. Is bipolar disorder specifically associated with aggression?. Bipolar Disord 14:283–290.
5. Ben-David E, Shifman S. 2012. Networks of neuronal genes affected by common and rare variants in autism spectrum disorders. PLoS Genetics 8:e1002556.
6. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. 1993. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578–580.
7. Burns A, Folstein S, Brandt J, Folstein M. 1990. Clinical assessment of irritability, aggression, and apathy in Huntington and Alzheimer disease. J Nerv Ment Dis 178:20–26.
8. Cha J, Fekete T, Siciliano F, Biezonski D, Greenhill L, Pliszka SR, Blader JC, Krain Roy A, Leibenluft E, Posner J. 2015. Neural Correlates of Aggression in Medication-Naive Children with ADHD: Multivariate Analysis of Morphometry and Tractography. Neuropsychopharmacology 40:1717–1725.
9. de Lacy N, King BH. 2013. Revisiting the relationship between autism and schizophrenia: Toward an integrated neurobiology. Annu Rev Clin Psychol 9:555–587.
10. Fatemi SH, Stary JM, Earle JA, Araghi-Niknam M, Eagan E. 2005. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and Reelin proteins in cerebellum. Schizophr Res 72:109–122.
11. Fisher CA, Sewell K, Brown A, Churchyard A. 2014. Aggression in Huntington's disease: A systematic review of rates of aggression and treatment methods. J Huntingtons Dis 3:319–332.
12. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E. 2000. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 57:1061–1069.
13. Hooper AJ, Burnett JR. 2013. Anti-PCSK9 therapies for the treatment of hypercholesterolemia. Expert Opin Biol Ther 13:429–435.
14. Lage K, Karlberg EO, Storling ZM, Olason PI, Pedersen AG, Rigina O, Hinsby AM, Tumer Z, Pociot F, Tommerup N, Moreau Y, Brunak S. 2007. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 25:309–316.
15. Lanz TA, Guilmette E, Gosink MM, Fischer JE, Fitzgerald LW, Stephenson DT, Pletcher MT. 2013. Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action. Molecular Autism 4:45.
16. Lee S, Lemere CA, Frost JL, Shea TB. 2012. Dietary supplementation with S-adenosyl methionine delayed amyloid-beta and tau pathology in 3xTg-AD mice. J Alzheimers Dis 28:423–431.
17. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, Andreassen OA, Anjorin A, Anney R, Anttila V, Arking DE, Asherson P, Azevedo MH, Backlund L, Badner JA, Bailey AJ, Banaschewski T, Barchas JD, Barnes MR, Barrett TB, Bass N, Battaglia A, Bauer M, Bayes M, Bellivier F, Bergen SE, Berrettini W, Betancur C, Bettecken T, Biederman J, Binder EB, Black DW, Blackwood DH, Bloss CS, Boehnke M, Boomsma DI, Breen G, Breuer R, Bruggeman R, Cormican P, Buccola NG, Buitelaar JK, Bunney WE, Buxbaum JD, Byerley WF, Byrne EM, Caesar S, Cahn W, Cantor RM, Casas M, Chakravarti A, Chambert K, Choudhury K, Cichon S, Cloninger CR, Collier DA, Cook EH, Coon H, Cormand B, Corvin A, Coryell WH, Craig DW, Craig IW, Crosbie J, Cuccaro ML, Curtis D, Czamara D, Datta S, Dawson G, Day R, De Geus EJ, Degenhardt F, Djurovic S, Donohoe GJ, Doyle AE, Duan J, Dudbridge F, Duketis E, Ebstein RP, Edenberg HJ, Elia J, Ennis S, Etain B, Fanous A, Farmer AE, Ferrier IN, Flickinger M, Fombonne E, Foroud T, Frank J, Franke B, Fraser C, Freedman R, Freimer NB, Freitag CM, Friedl M, Frisen L, Gallagher L, Gejman PV, Georgieva L, Gershon ES, Geschwind DH, Giegling I, Gill M, Gordon SD, Gordon-Smith K, Green EK, Greenwood TA, Grice DE, Gross M, Grozeva D, Guan W, Gurling H, De Haan L, Haines JL, Hakonarson H, Hallmayer J, Hamilton SP, Hamshere ML, Hansen TF, Hartmann AM, Hautzinger M, Heath AC, Henders AK, Herms S, Hickie IB, Hipolito M, Hoefels S, Holmans PA, Holsboer F, Hoogendijk WJ, Hottenga JJ, Hultman CM, Hus V, Ingason A, Ising M, Jamain S, Jones EG, Jones I, Jones L, Tzeng JY, Kahler AK, Kahn RS, Kandaswamy R, Keller MC, Kennedy JL, Kenny E, Kent L, Kim Y, Kirov GK, Klauck SM, Klei L, Knowles JA, Kohli MA, Koller DL, Konte B, Korszun A, Krabbendam L, Krasucki R, Kuntsi J, Kwan P, Landen M, Langstrom N, Lathrop M, Lawrence J, Lawson WB, Leboyer M, Ledbetter DH, Lee PH, Lencz T, Lesch KP, Levinson DF, Lewis CM, Li J, Lichtenstein P, Lieberman JA, Lin DY, Linszen DH, Liu C, Lohoff FW, Loo SK, Lord C, Lowe JK, Lucae S, MacIntyre DJ, Madden PA, Maestrini E, Magnusson PK, Mahon PB, Maier W, Malhotra AK, Mane SM, Martin CL, Martin NG, Mattheisen M, Matthews K, Mattingsdal M, McCarroll SA, McGhee KA, McGough JJ, McGrath PJ, McGuffin P, McInnis MG, McIntosh A, McKinney R, McLean AW, McMahon FJ, McMahon WM, McQuillin A, Medeiros H, Medland SE, Meier S, Melle I, Meng F, Meyer J, Middeldorp CM, Middleton L, Milanova V, Miranda A, Monaco AP, Montgomery GW, Moran JL, Moreno-De-Luca D, Morken G, Morris DW, Morrow EM, Moskvina V, Muglia P, Muhleisen TW, Muir WJ, Muller-Myhsok B, Murtha M, Myers RM, Myin-Germeys I, Neale MC, Nelson SF, Nievergelt CM, Nikolov I, Nimgaonkar V, Nolen WA, Nothen MM, Nurnberger JI, Nwulia EA, Nyholt DR, O'Dushlaine C, Oades RD, Olincy A, Oliveira G, Olsen L, Ophoff RA, Osby U, Owen MJ, Palotie A, Parr JR, Paterson AD, Pato CN, Pato MT, Penninx BW, Pergadia ML, Pericak-Vance MA, Pickard BS, Pimm J, Piven J, Posthuma D, Potash JB, Poustka F, Propping P, Puri V, Quested DJ, Quinn EM, Ramos-Quiroga JA, Rasmussen HB, Raychaudhuri S, Rehnstrom K, Reif A, Ribases M, Rice JP, Rietschel M, Roeder K, Roeyers H, Rossin L, Rothenberger A, Rouleau G, Ruderfer D, Rujescu D, Sanders AR, Sanders SJ, Santangelo SL, Sergeant JA, Schachar R, Schalling M, Schatzberg AF, Scheftner WA, Schellenberg GD, Scherer SW, Schork NJ, Schulze TG, Schumacher J, Schwarz M, Scolnick E, Scott LJ, Shi J, Shilling PD, Shyn SI, Silverman JM, Slager SL, Smalley SL, Smit JH, Smith EN, Sonuga-Barke EJ, St Clair D, State M, Steffens M, Steinhausen HC, Strauss JS, Strohmaier J, Stroup TS, Sutcliffe JS, Szatmari P, Szelinger S, Thirumalai S, Thompson RC, Todorov AA, Tozzi F, Treutlein J, Uhr M, van den Oord EJ, Van Grootheest G, Van Os J, Vicente AM, Vieland VJ, Vincent JB, Visscher PM, Walsh CA, Wassink TH, Watson SJ, Weissman MM, Werge T, Wienker TF, Wijsman EM, Willemsen G, Williams N, Willsey AJ, Witt SH, Xu W, Young AH, Yu TW, Zammit S, Zandi PP, Zhang P, Zitman FG, Zollner S, Devlin B, Kelsoe JR, Sklar P, Daly MJ, O'Donovan MC, Craddock N, Sullivan PF, Smoller JW, Kendler KS, Wray NR. 2013. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genet 45:984–994.
18. Lichtenstein P, Carlstrom E, Rastam M, Gillberg C, Anckarsater H. 2010. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry 167:1357–1363.
19. Ma HW, Zhao XM, Yuan YJ, Zeng AP. 2004. Decomposition of metabolic network into functional modules based on the global connectivity structure of reaction graph. Bioinformatics 20:1870–1876.
20. Malki K, Pain O, Du Rietz E, Tosto MG, Paya-Cano J, Sandnabba KN, de Boer S, Schalkwyk LC, Sluyter F. 2014. Genes and Gene Networks Implicated in Aggression Related Behaviour. Neurogenetics.
21. McKusick VA. 1998. Mendelian Inheritance in Man. A Catalog of Human Genes and Genetic Disorders. Baltimore: Johns Hopkins University Press.
22. Miles DR, Carey G. 1997. Genetic and environmental architecture of human aggression. J Pers Soc Psychol 72:207–217.
23. Oh YS, Lee JE, Lee PH, Kim JS. 2015. Neuropsychiatric symptoms in Parkinson's disease dementia are associated with increased caregiver burden. J Mov Disord 8:26–32.
24. Onuora S. 2012. Crystal arthritis: Canakinumab relieves gout flares when treatment options are limited. Nat Rev Rheumatol 8:369.
25. Philips AK, Siren A, Avela K, Somer M, Peippo M, Ahvenainen M, Doagu F, Arvio M, Kaariainen H, Van Esch H, Froyen G, Haas SA, Hu H, Kalscheuer VM, Jarvela I. 2014. X-exome sequencing in Finnish families with intellectual disability-four novel mutations and two novel syndromic phenotypes. Orphanet J Rare Dis 9:49.
26. Pivovarciova A, Hnilicova S, Ostatnikova D, Mace FC. 2014. Testosterone and explosive aggression in autism spectrum disorders. Neuro Endocrinol Lett 35:553–559.
27. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL. 2002. Hierarchical organization of modularity in metabolic networks. Science 297:1551–1555.
28. Rojahn J, Borthwick-Duffy SA, Jacobson JW. 1993. The association between psychiatric diagnoses and severe behavior problems in mental retardation. Ann Clin Psychiatry 5:163–170.
29. Rossin EJ, Lage K, Raychaudhuri S, Xavier RJ, Tatar D, Benita Y, Cotsapas C, Daly MJ. 2011. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS genetics 7:e1001273.
30. Sakai Y, Shaw CA, Dawson BC, Dugas DV, Al-Mohtaseb Z, Hill DE, Zoghbi HY. 2011. Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med 3:86ra 49.
31. Sandyk R. 1993. Aggressive behavior in schizophrenia: relationship to age of onset and cortical atrophy. Int J Neurosci 68:1–10.
32. Saudou F, Amara DA, Dierich A, LeMeur M, Ramboz S, Segu L, Buhot MC, Hen R. 1994. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265:1875–1878.
33. Schlesinger N. 2012. Canakinumab in gout. Expert opinion on biological therapy 12:1265–1275.
34. Seo TB, Cho HS, Shin MS, Kim CJ, Ji ES, Baek SS. 2013. Treadmill exercise improves behavioral outcomes and spatial learning memory through up-regulation of reelin signaling pathway in autistic rats. J Exerc Rehabil 9:220–229.
35. Sharma A, Chavali S, Mahajan A, Tabassum R, Banerjee V, Tandon N, Bharadwaj D. 2005. Genetic association, post-translational modification, and protein-protein interactions in Type 2 diabetes mellitus. Molecular & cellular proteomics: MCP 4:1029–1037.
36. Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI, Ripke S, Santangelo S, Sullivan PF. 2013. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381:1371–1379.
37. Sokol DK, Chen D, Farlow MR, Dunn DW, Maloney B, Zimmer JA, Lahiri DK. 2006. High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol 21:444–449.
38. Urban D, Poss J, Bohm M, Laufs U. 2013. Targeting the proprotein convertase subtilisin/kexin type 9 (PCSK9) for the treatment of dyslipidemia and atherosclerosis. J Am Coll Cardiol. 62(16):1401–1408.
39. Vassos E, Collier DA, Fazel S. 2014. Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression. Mol Psychiatry 19:471–477.
40. Verma D, Eriksson P, Sahdo B, Persson A, Ejdeback M, Sarndahl E, Soderkvist P. 2010. Two adult siblings with atypical cryopyrin-associated periodic syndrome due to a novel M299V mutation in NLRPS. Arthritis Rheum 62:2138–2143.
41. Veroude K, Y Z-J, Fernàndez-Castillo N, Bakker M, Cormand B, SV F. 2015. Genetics of Aggressive Behavior: An Overview. Am J Med Genet B Neuropsychiatr Genet (RDoc Special Issue). In press.